focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Kingswood buys wealth manager; Helios capacity grows

Mon, 15th Nov 2021 19:13

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Kingswood Holdings Ltd - London-based wealth manager - Agrees to acquire Money Matters Ltd, a privately owned wealth management business, primarily offering its services in the North East of England, for total cash consideration of GBP3.4 million, paid over 2 years. Notes GBP1.7 million will be paid immediately, with further GBP1.7 million paid on achievement of performance targets. Money Maters North East business holds about GBP115 million assets under administration from about 600 clients. Kingswood's UK CEO David Lawrence says: "We remain committed to perpetuating our stated growth strategy within the UK and internationally. This is our second acquisition of 2021 and we continue to have a strong pipeline of high-quality UK opportunities under negotiation, six of which are in exclusive due diligence as we continue to grow our financial planning and investment management reach across the UK. We expect to be making more announcements over the coming weeks.''

----------

Schroder Real Estate Investment Trust Ltd - invests in UK commercial real estate, seeking income and capital growth from active management - Exchanges or completes 13 new lettings, renewals and reviews which will generate GBP300,000 per annum of rental income and increase contracted rental income by GBP185,000 per annum since September 20. Notes set to deliver 80,000 square foot of operationally net zero carbon industrial, storage and distribution space at Stanley Green Trading Estate after receipt of a resolution to grant planning permission.

----------

Helios Underwriting PLC - London-based investment vehicle, which acquires and consolidates underwriting capacity at Lloyd's - Notes December 31 expected capacity value to rise to GBP60.2 million from GBP30.8 million a year earlier. Expecting to acquire 29 LLVs during 2021 with capacity of GBP35.4 million, which was valued at 2021 capacity prices at GBP18.0 million. Chief Executive Nigel Hanbury says: "I am delighted that the value of the capacity portfolio will increase to GBP60 million with the revaluation of the existing portfolio adding 9.6p to the tangible net asset value per share - a 6.6% increase." Company adds: "Helios continued to manage the capacity portfolio discarding unwanted syndicates and taking positions on syndicates, in particular syndicate 510 and syndicate 2689, taking the total additional capacity acquired at auction to GBP23.8 million for consideration of GBP2.6 million."

----------

Thalassa Holdings Ltd - British Virgin Islands-based investment company in real estate, fintech and robotics - Subsidiary id4 delivers "client space solution" to Swiss-based asset manager Geneva Management Group. "The id4 client space solution, delivered using cloud-based technology, will enable GMG to onboard clients remotely and to review KYC profiles periodically," company says.

----------

Insig AI PLC - London-based machine learning and data science firm serving asset management industry, formerly known as Catena - Signs proof of concept exercise with unnamed European asset manager with assets under management of several billion euros. "In this initial proof-of-concept exercise on one of the client's larger funds, valued in excess of EUR1 billion, Insig AI has been tasked to use its machine learning data and expertise to analyse and categorise the client's portfolio," company says.

----------

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - US partner Eton Pharmaceuticals signs co-promotion deal for Alkindi Sprinkle with Tolmar Pharmaceuticals. As part of deal, Tolmar's 62-person sales force will promote Alkindi Sprinkle to their paediatric endocrinology targets alongside its own existing product. "Eton has indicated that it expects the co-promotion agreement to translate to significantly faster adoption of Alkindi Sprinkle and to accelerate the time to reach peak conversion of patients from existing therapy. The terms of Diurnal's licensing agreement with Eton are unaffected by Eton's agreement with Tolmar," Diurnal says.

----------

Panthera Resources PLC - gold exploration and development company with assets in West Africa and India - Settles agreements with Metal Mining India Private Ltd to buy its Indian joint venture partner for AUD1.8 million, just under GBP1 million. Issues 3.0 million shares and pays GBP500,000 to close deal. Notes ownership interest in the Bhukia and Taregaon projects in India via IGL has increased to 100%, giving Panthera a 95% interest, if prospecting licences are granted in the future.

----------

Mkango Resources Ltd - Vancouver-based explorer for rare earth elements - German subsidiary HyProMag Ltd creates new business HyProMag GmbH alongside Pforzheim University professor Carlo Burkhardt. HyProMag will own 80% of new business, while Burkhardt will take own remaining 20%. "Germany is a major producer and market for rare earth magnets in Europe, and the establishment of HyProMag GmbH provides a strong platform to grow the business in the region. Germany has no domestic sources of primary rare earths. Development of domestic sources of recycled rare earths via the patented HPMS is a significant opportunity to diversify and strengthen development of a more resilient rare earths supply chain in Europe," company explains.

----------

W Resources PLC- tungsten, tin and gold mining and exploring in Spain and Portugal - Raises GBP750,000 from placing 12.5 million shares at 6 pence each. "Following the award of the mining licence at the Régua tungsten mine in Portugal, the majority of the funds raised from the placing will be used to progress the mine development and to accelerate the environmental impact study report this quarter, as the team works towards first production in the second half of 2022," company says. Notes it will also use part of the funds at the La Parrilla mine in Spain to improve the laboratories, finished goods warehouse and spare parts warehouse. Enlarged share capital now 133.1 million.

----------

Bradda Head Lithium Ltd - Isle of Man-based exploration and mining services provider - Signs binding letter of intent for royalty agreement with Lithium Royalty Corp for 2% gross overriding royalty for sedimentary lithium claims in central Arizona. Value of agreement worth USD8 million. Notes USD2.5 million will be paid on closing of deal, USD2.5 million will be paid after Bradda obtains 1 million tonnes lithium carbonate equivalent; and finally, USD3 million to be paid after Bradda obtains 2.5 million tonnes lithium. Chief Executive Charles FitzRoy says: "We are delighted that Lithium Royalty Corporation has chosen to partner with us. This agreement further endorses the confidence in and inherent value that we believe our assets have; as well as in the future potential of the Company and our strategy given LRC's investment in Bradda."

----------

Chaarat Gold Holdings Ltd - gold miner in Armenia and mine developer in Kyrgyz Republic - Chief Financial Office Chris Eger to leave firm on November 30. Company says CFO will "pursue other opportunities". "Chris leaves with the board's appreciation and thanks for the role he has played in the development of Chaarat over the last three years," company adds. Starts search for replacement, and says current management team will assume Eger's responsibilities.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
28 Oct 2022 21:18

TRADING UPDATES: SulNOx, Marwyn loss widens; Kropz gets new facility

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
21 Oct 2022 21:29

TRADING UPDATES: Trackwise Designs wins deal; Cake Box names CFO

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
14 Oct 2022 15:48

UK shareholder meetings calendar - next 7 days

Monday 17 October 
Arcontech Group PLCAGM
Barratt Developments PLCAGM
Eight Capital Partners PLCGM re IWEP loan conversion to equity
Tuesday 18 October 
Accrol Group Holdings PLCAGM
Diverse Income TrustAGM
Dolphin Capital Investors LtdAGM
Pantheon International PLCAGM
Tlou Energy LtdAGM
Wednesday 19 October 
Empyrean Energy PLCGM annual report approval
Frasers Group PLCAGM
Hargreaves Lansdown PLCAGM
HydrogenOne Capital Growth PLCGM share issuance programme
Made Tech Group PLCAGM
SME Credit Realisation Fund LtdAGM
Thursday 20 October 
abrdn UK Smaller Companies Growth Trust PLCAGM
Argo Group LtdAGM
Dechra Pharmaceuticals PLCAGM
DX Group PLCGM re 2021 financial year annual report
Gateley Holdings PLCAGM
Science in Sport PLCGM 
Xeros Technology Group PLCGM capital reorganisation
Friday 21 October 
Diurnal Group PLCGM re Neurocrine takeover
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
7 Oct 2022 13:01

Diurnal treatment gets approval from Welsh regulatory body

(Alliance News) - Diurnal Group PLC on Friday said its Efmody treatment has been recommended as an option to treat patients with congenital adrenal hyperplasia.

Read more
7 Oct 2022 11:31

Diurnal's 'Efmody' treatment gets thumbs-up for NHS Wales

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Friday that the All-Wales Medicines Strategy Group (AWMSG) has recommended its 'Efmody' hydrocortisone modified-release hard capsules as an option for restricted use to treat adolescents and adults with congenital adrenal hyperplasia (CAH) within NHS Wales.

Read more
14 Sep 2022 11:40

Diurnal annual loss widens despite revenue growth as costs balloon

(Alliance News) - Diurnal Group PLC on Wednesday reported a widened annual loss as costs, especially on research & development, surged.

Read more
7 Sep 2022 15:53

UK earnings, trading statements calendar - next 7 days

Thursday 8 September 
Arecor Therapeutics PLCHalf Year Results
Cairn Homes PLCHalf Year Results
Chaarat Gold Holdings LtdHalf Year Results
Curtis Banks Group PLCHalf Year Results
Darktrace PLCFull Year Results
Destiny Pharma Holdings PLCHalf Year Results
Duke Royalty LtdFull Year Results
Emis Group PLCHalf Year Results
Energean PLCHalf Year Results
Funding Circle Holdings PLCHalf Year Results
Genus PLCFull Year Results
International Public Partnerships LtdHalf Year Results
Melrose Industries PLCHalf Year Results
Mpac Group PLCHalf Year Results
M Winkworth PLCHalf Year Results
Oakley Capital Investments LtdHalf Year Results
Open Orphan PLCHalf Year Results
Restaurant Group PLCHalf Year Results
Safestore Holdings PLCQ3 Results
Severfield PLCFull Year Results
Shield Therapeutics PLCHalf Year Results
SourceBio International PLCHalf Year Results
Spire Healthcare Group PLCHalf Year Results
Sylvania Platinum LtdFull Year Results
Vistry Group PLCHalf Year Results
Friday 9 September 
Computacenter PLCHalf Year Results
Creo Medical Group PLCHalf Year Results
Mid Wynd International Investment Trust PLCFull Year Results
Monday 12 September 
ABCAM PLCHalf Year Results
Arcontech Group PLCFull Year Results
Associated British Foods PLCFull Year Results
Greencoat Renewables PLCHalf Year Results
HgCapital Trust PLCHalf Year Results
Kape Technologies PLCHalf Year Results
Made Tech Group PLCFull Year Results
MP Evans Group PLCHalf Year Results
SigmaRoc PLCHalf Year Results
Tirupati Graphite PLCFull Year Results
Tuesday 13 September 
accesso Technology Group PLCHalf Year Results
Churchill China PLCHalf Year Results
Corero Network Security PLCHalf Year Results
Engage XR Holdings PLCHalf Year Results
Facilities by ADF PLCHalf Year Results
Fevertree Drinks PLCHalf Year Results
Futura Medical PLCHalf Year Results
Gateley Holdings PLCFull Year Results
Harworth Group PLCHalf Year Results
HeiQ PLCHalf Year Results
JTC PLCHalf Year Results
Mattioli Woods PLCFull Year Results
Ocado Group PLCTrading Statement
Oxford Nanopore Technologies PLCHalf Year Results
Petra Diamonds LtdFull Year Results
Property Franchise Group PLCHalf Year Results
RBG Holdings PLCHalf Year Results
Smart Metering Systems PLCHalf Year Results
Team17 Group PLCHalf Year Results
Trustpilot Group PLCHalf Year Results
VH Global Sustainable Energy Opportunities PLCHalf Year Results
Wednesday 14 September 
Anpario PLCHalf Year Results
Advanced Medical Solutions Group PLCHalf Year Results
BioPharma Credit PLCHalf Year Results
Blackbird PLCHalf Year Results
Central Asia Metals PLCHalf Year Results
Diurnal Group PLCHalf Year Results
Dunelm Group PLCFull Year Results
Epwin Group PLCHalf Year Results
Glenveagh Properties PLCHalf Year Results
ITM Power PLCFull Year Results
Niox Group PLCHalf Year Results
Pan African Resources PLCFull Year Results
Pharos Energy PLCHalf Year Results
Redrow PLCFull Year Results
Ricardo PLCFull Year Results
STM Group PLCHalf Year Results
Artisanal Spirits Co PLCHalf Year Results
Tullow Oil PLCHalf Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
30 Aug 2022 17:04

LONDON MARKET CLOSE: Stocks move into reverse as pessimism takes over

(Alliance News) - Stocks in London returned from the long weekend on Tuesday to close in the red despite spending most of the session in the green, as investors wiped out the morning's gains following selling pressure in the US.

Read more
30 Aug 2022 14:55

Diurnal to be taken over by Neurocrine Biosciences for £48.3m, shares surge

(Sharecast News) - Diurnal shares surged on Tuesday after it agreed to be taken over by US biotech firm Neurocrine Biosciences for £48.3m.

Read more
30 Aug 2022 12:47

Diurnal shares double on GBP48 million takeover from Neurocrine

(Alliance News) - Diurnal Group PLC on Tuesday said it agreed to a GBP48.3 million takeover from US biopharmaceutical firm Neurocrine Biosciences Inc.

Read more
30 Aug 2022 11:04

AIM WINNERS & LOSERS: Diurnal shares more than double on takeover bid

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
26 Jul 2022 12:03

IN BRIEF: Diurnal more than doubles product sales in 2022

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - Says product sales in the year ended June 30, more than doubled to GBP4.6 million from GBP2.3 million the previous year. Revenue in the year totals GBP4.7 million including licensing income of GBP600,000, up from GBP4.4 million the previous year, including licensing income of GBP2.1 million.

Read more
1 Jun 2022 19:41

TRADING UPDATES: Indivior, Diurnal start trials; Alien Metals tests

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
9 May 2022 14:01

Director dealings: K3 director linked to purchase, Diurnal exec sells shares into ISA

(Sharecast News) - Software company K3 Business Technology was at the top of the list of buys on Monday, after Kestrel Partners spent more than £40k on its shares.

Read more
25 Apr 2022 19:19

IN BRIEF: Diurnal expands distribution agreement with EffRx

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - Extends distribution and marketing agreement with EffRx Pharmaceuticals in Switzerland to include Efmody.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.